Suvoda and Greenphire Complete Their Brand Integration
Suvoda LLC, a global leader in clinical trial technology, has officially finalized its brand integration with Greenphire. This significant milestone was announced on September 24, 2025, and marks a new era for both companies as they unite under the Suvoda brand name. This integration comes as a continuation of their efforts to merge resources for a more comprehensive technology platform aimed at improving clinical trial execution and patient participation.
The merger between Suvoda and Greenphire, which was initially disclosed in April 2025, now culminates in a cohesive brand that simplifies the complexities involved in clinical trial processes. Following this integration, the companies have consolidated their social media presence, notably on LinkedIn, and launched an updated website that collates the entire range of their products and services at suvoda.com.
Enhancements in Patient-Centric Solutions
Focus on patient-centric solutions remains a core objective of Suvoda. The innovations in product offerings are designed to enhance patient journeys while improving operational efficiency and data quality across clinical trials. The newly formed Suvoda platform offers a seamless real-time experience to patients, study sites, sponsors, and contract research organizations (CROs) through the integration of eight key products:
- - IRT (Interactive Response Technology)
- - eCOA (Electronic Clinical Outcome Assessments)
- - Greenphire Patient Payments (formerly ClinCard)
- - Greenphire Travel (formerly Concierge Services and Connex)
- - eConsent
- - Scheduling (formerly ePatient)
- - Greenphire Clinical Finance Suite, including Site Payments (formerly eClinicalGPS) and Budgeting Benchmarking (formerly EnvisiX)
Over the upcoming months, Suvoda plans to further unify all solutions, enabling study sites and sponsors to benefit from a single sign-on system, an intuitive user interface, one patient app, and a shared data layer for real-time access across all solutions. This integration aims to streamline various processes and improve the overall experience for all stakeholders involved in clinical trials.
Vision for a Simplified Patient Experience
Jagath Wanninayake, CEO of Suvoda, emphasized the company’s vision by stating, "Our aim is to simplify the patient experience at every stage—whether operational, logistical, or financial. We want clinical trials to be more responsive, connected, and easier for patients to navigate."
As the rebranding progresses, stakeholders using Suvoda products will observe a fresh brand aesthetic, including a unified color palette and logo across all offerings. Additionally, the company plans to introduce a centralized launchpad on the platform, providing unified access to all educational software.
Suvoda continues to offer high-quality products, services, and innovations paired with the advanced technology and knowledgeable support essential for managing mission-critical aspects of clinical trials. Throughout the integration process, Suvoda remains committed to closely collaborating with sponsors, sites, and patients to ensure the successful execution of studies.
About Suvoda
Suvoda is a globally recognized company in the field of clinical trials, providing a real-time experiential platform that empowers sponsors and CROs to make informed decisions while enabling study sites and patients to take controlled actions. With interconnected, action-oriented software solutions and industry-leading services and support, Suvoda drives critical studies even during the most time-sensitive and mission-critical moments. Headquartered just outside of Philadelphia, the company maintains additional offices in Portland (Oregon), Barcelona (Spain), Bucharest and Iasi (Romania), and Tokyo (Japan). Suvoda records customer satisfaction ratings exceeding technology industry averages, a testament to its selection by study sponsors and CROs for over 2,000 studies in over 95 countries. For more information, please visit suvoda.com and follow Suvoda on LinkedIn.